Xia Zhongjun
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma (NCT05422027) | Xia Zhongjun | 2022-07-25 |
Track Xia Zhongjun automatically
Every clearance here is in the API, with alerts when new ones post.